A monoclonal antibody against human complement component C3: the production of C3 by human cells in vitro.

A monoclonal antibody against human complement component C3: the production of C3 by human cells in vitro.

A monoclonal antibody (WM1) against the third component of human complement (C3) was produced by fusing P3-X63-Ag8 mouse myeloma cells with spleen cells from BALB/c mice immunized with purified C3. The specificity of WM1 antibody against C3 was established by its capacity to inhibit a standard C3 he...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Whitehead, A, Sim, R, Bodmer, W
Format:	Journal article
Język:	English
Wydane:	1981

Podobne zapisy

MONOCLONAL-ANTIBODIES AGAINST HUMAN C-3
od: Whitehead, A, i wsp.
Wydane: (1980)

PRODUCTION OF MONOCLONAL ANTIBODY AGAINST HUMAN IMMUNOGLOBULIN
od: J. Majidi, i wsp.
Wydane: (2000-04-01)

Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis
od: Lin-Lin Li, i wsp.
Wydane: (2019-12-01)

The first component of human complement
od: Sim, R
Wydane: (1976)

C3 and C4 complement components in autoimmune hepatitis.
od: Eman Sh. AL-Obeidy, i wsp.
Wydane: (2007-10-01)

Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species
od: Wioleta M. Zelek, i wsp.
Wydane: (2020-12-01)

A MONOCLONAL-ANTIBODY TO SPECIFIC HUMAN EPIDERMAL-CELL LAYERS
od: Goldsmith, L, i wsp.
Wydane: (1980)

Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2.
od: Parham, P, i wsp.
Wydane: (1978)

Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer
od: Kiefer Hans, i wsp.
Wydane: (2009-06-01)

Human complement component C3 N-glycome changes in type 1 diabetes complications
od: Dinko Šoić, i wsp.
Wydane: (2023-05-01)

Conversion of the C3 component of complement in sera of hanseniasis patients
od: Teresa A. E. Kliemann, i wsp.
Wydane: (1983-06-01)

Intramolecular general acid catalysis in the binding reactions of alpha 2-macroglobulin and complement components C3 and C4.
od: Davies, S, i wsp.
Wydane: (1981)

Monoclonal Antibody Production against Human Spermatozoal Surface Antigens
od: M Jedi-Tehrani, i wsp.
Wydane: (2005-10-01)

Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity <it>in-vitro: </it>an alternative treatment for C2 deficiency diseases
od: Martini Paolo GV, i wsp.
Wydane: (2010-08-01)

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy
od: Sophie Chauvet, i wsp.
Wydane: (2018-10-01)

The gene structure and the polymorphism of the human complement component C4
od: Yu, C, i wsp.
Wydane: (1987)

Evaluation of complement components C3 and C4 in serum of patient with neoplastic diseases
od: Zeenah weheed Atwan, i wsp.
Wydane: (2019-06-01)

Evaluation of complement components C3 and C4 in serum of patient with neoplastic diseases
od: Zeenah weheed Atwan, i wsp.
Wydane: (2019-06-01)

Evaluation of complement components C3 and C4 in serum of patient with neoplastic diseases
od: Zeenah weheed Atwan, i wsp.
Wydane: (2019-06-01)

4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis
od: Jérôme Granel, i wsp.
Wydane: (2020-09-01)

Downhill running does not alter blood C1q availability or complement-dependent cytotoxicity of therapeutic monoclonal antibodies against haematological cancer cell lines in vitro
od: Harrison D. Collier-Bain, i wsp.
Wydane: (2024-11-01)

Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
od: Bindon, C, i wsp.
Wydane: (1988)

Monoclonal antibodies effectively potentiate complement activation and phagocytosis of Staphylococcus epidermidis in neonatal human plasma
od: Lisanne de Vor, i wsp.
Wydane: (2022-07-01)

Estimation of Complement Components (C3 and C4) and hs-CRP Level in Kidney Failure Patients
od: Zaid N. Elia, i wsp.
Wydane: (2019-12-01)

Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement.
od: Ezekowitz, R, i wsp.
Wydane: (1985)

Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody
od: Leon Cyranka, i wsp.
Wydane: (2023-11-01)

Production and Characterization of Monoclonal Antibodies Against the Dimerization Domain of Human HER2
od: Nadri, i wsp.
Wydane: (2015-07-01)

Allele frequencies of the third component of complement (C3) in MS patients.
od: Bulman, D, i wsp.
Wydane: (1991)

Complement Component C3 Binds to the A3 Domain of von Willebrand Factor
od: Jennifer G. Nolasco, i wsp.
Wydane: (2018-07-01)

Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines
od: Sára Kellnerová, i wsp.
Wydane: (2020-12-01)

Investigation of complement component C4 copy number variation in human longevity.
od: Friederike Flachsbart, i wsp.
Wydane: (2014-01-01)

C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates
od: Robin Schmitz, i wsp.
Wydane: (2021-09-01)

Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro and in vivo biofilm
od: Lisanne de Vor, i wsp.
Wydane: (2022-01-01)

Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.
od: Parham, P, i wsp.
Wydane: (1979)

Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality
od: Nicolas Aubrey, i wsp.
Wydane: (2022-08-01)

Monoclonal antibody targeting complement C9 binding domain of Trichinella spiralis paramyosin impairs the viability of Trichinella infective larvae in the presence of complement
od: Yuwan Hao, i wsp.
Wydane: (2014-07-01)

Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1
od: Elena Boero, i wsp.
Wydane: (2023-01-01)

P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS
od: A. Wiestner, i wsp.
Wydane: (2022-06-01)

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.
od: Hale, G, i wsp.
Wydane: (1983)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
od: Cobbold, S, i wsp.
Wydane: (1990)